Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Fractional Flow Reserve to Determine the ApproprIateness of Percutaneous Renal Artery Intervention in Atherosclerosis Renovascular Hypertension Patients: a Pilot Randomized Trial

NCT05732077 is registered in ClinicalTrials.gov with Peking University First Hospital as lead sponsor.

NCT NCT05732077
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05732077 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Fractional Flow Reserve to Determine the ApproprIateness of Percutaneous Renal Artery Intervention in Atherosclerosis Renovascular Hypertension Patients: a Pilot Randomized Trial
Lead sponsor
Peking University First Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
January 31, 2023
Completion date
March 31, 2025
Enrollment
100 (estimated)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

renal artery stenosis atherosclerotic, secondary hypertension renal arterial